Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

Clinical trial NCT07673211 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07673211
Sponsor: Zhejiang Cancer Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Cervical Cancer Recurrent Cervical Cancer Metastatic Cervical Cancer

Start date: 2026-06-01
Primary completion: 2028-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.